0 0 0.000375975185637807 0.00281981389228308 -0.000845944167684965 0.000281981389228322 -0.015508976407557 -0.00986934862299086
Sign Up Today X
Thanks for submitting the form.
Stockreport

Alterome Therapeutics Announces New Chief Executive Officer and Chair of the Board of Directors [Yahoo! Finance]

Gilead Sciences, Inc. (GILD)  More Company Research Source: Yahoo! Finance
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
at companies including Global Blood Therapeutics, Gilead Sciences, and Third Rock Ventures Richard Heyman, Ph.D., a senior advisor to the company since its inception, named as Chair of the Board of Directors SAN DIEGO, April 10, 2025 BUSINESS WIRE Alterome Therapeutics, Inc. , a clinical-stage biopharmaceutical company pioneering the development of next-generation, small molecule targeted therapies for the treatment of cancer, today announced the appointment of Jung Choi as Chief Executive Officer (CEO) and Richard Heyman, Ph.D., as Chair of the Board of Directors. Ms. Choi brings significant experience in growing companies from privately held, preclinical to publicly traded, commercial-stage organizations. Dr. Heyman is a scientist and entrepreneur with more than 25 years of experience in co-founding and building biotech and life science companies. "Jung's deep experience in building innovative portfolios and effectively scaling organizations will be invaluable to Alterome as [Read more]
IMPACT SNAPSHOT EVENT TIME: GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
GILD alerts
from News Quantified
GILD
NEWS
GILD
Earnings
GILD
Analyst Actions
GILD
SEC Filings
Stockreport

Alterome Therapeutics Announces New Chief Executive Officer and Chair of the Board of Directors [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
More Company Research Source: Yahoo! Finance
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
at companies including Global Blood Therapeutics, Gilead Sciences, and Third Rock Ventures Richard Heyman, Ph.D., a senior advisor to the company since its inception, named as Chair of the Board of Directors SAN DIEGO, April 10, 2025 BUSINESS WIRE Alterome Therapeutics, Inc. , a clinical-stage biopharmaceutical company pioneering the development of next-generation, small molecule targeted therapies for the treatment of cancer, today announced the appointment of Jung Choi as Chief Executive Officer (CEO) and Richard Heyman, Ph.D., as Chair of the Board of Directors. Ms. Choi brings significant experience in growing companies from privately held, preclinical to publicly traded, commercial-stage organizations. Dr. Heyman is a scientist and entrepreneur with more than 25 years of experience in co-founding and building biotech and life science companies. "Jung's deep experience in building innovative portfolios and effectively scaling organizations will be invaluable to Alterome as [Read more]
IMPACT SNAPSHOT
EVENT TIME:
GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS